Najlepsi lekarze wykonujący plazmaferezę – TOP 20 lekarzy

Dr. Siriporn Cheawchanwej is an aesthetic and anti-aging physician. She holds a Diploma in Aesthetic Medicine from the American Academy of Aesthetic Medicine and completed advanced training at the School of Anti-Aging and Regenerative Medicine and in Facial Design at Mae Fah Luang University.

Her international training includes Restylane seminars in Sweden (2006–2008) and the International Symposium of Botulinum Toxin in Korea. She also attended the Asia Pacific Rhinoplasty Expert Forum in Seoul, the International Congress of Minimal Invasive Plastic Surgery & Dermatology in Seoul, and IMCAS Asia 2009.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Eslie Perez wnosi specjalistyczne doświadczenie w procedurach dermatologicznych i małoinwazyjnych do swojej praktyki w Holistic Bio Spa®.

• Kierownik ds. nauczania w Szpitalu Regionalnym w Puerto Vallarta
• Certyfikowana w zakresie biomagnetyzmu w leczeniu holistycznym
• Przeszkolona w zakresie lasera frakcyjnego i IPL do odmładzania twarzy
• Doświadczenie w stosowaniu botoksu, wypełniaczy i fototerapii UV

Dr Aygun Mammadova specjalizuje się w neurologii integracyjnej i osteopatii, lecząc złożone schorzenia układu nerwowego w Centrum Zdrowia Integracyjnego „Medycyna Biologiczna” w Baku.

• Ukończyła szkolenia na Azerbejdżańskim Uniwersytecie Medycznym oraz w Akademii Osteopatii w Petersburgu
• Brała udział w międzynarodowych kongresach neurologicznych w Niemczech, Szwajcarii i Turcji
• Ekspert w leczeniu choroby Parkinsona, stwardnienia rozsianego oraz zwyrodnieniowych chorób układu nerwowego
• Stosuje metody osteopatyczne w połączeniu z konwencjonalną neurologią w celu zapewnienia kompleksowej opieki

Dr Topcular specjalizuje się w neurologii i posiada bogate doświadczenie w przeprowadzaniu plazmaferezy w szpitalu Florence Nightingale.

• Kształcił się na Wydziale Medycznym Cerrahpaşa Uniwersytetu Stambulskiego
• Pracował w Klinice Neurologii Uniwersytetu w Bazylei oraz w Centrum Badawczym PharmaZentrum
• Praktykuje w wielu lokalizacjach szpitala Florence Nightingale
• Członek Wydziału Neurologii Uniwersytetu Bilim w Stambule

Dr Amnon specjalizuje się w plazmaferezie w Centrum Medycznym Sourasky (Ichilov), oferując zaawansowane metody leczenia skomplikowanych schorzeń.

• Ukończył Uniwersytet Telawiwski w 1988 roku
• Uzyskał kwalifikacje w medycynie chińskiej na Sri Lance
• Ekspertyza w zakresie stymulacji nerwu błędnego i plazmaferezy

Dr Romero Imbroda kieruje Oddziałem Neurologii w Quirónsalud Marbella, specjalizując się w zaawansowanych metodach leczenia złożonych schorzeń neurologicznych.

• Ordynator Oddziałów Neurologii w szpitalach Quirónsalud w Maladze i Marbelli
• Autor publikacji na temat stwardnienia rozsianego i innych zaburzeń neurologicznych
• Członek European Board of Neurology
• Członek akademicki Królewskiej Akademii Medycznej Wschodniej Andaluzji
• Profesor Uniwersytetu w Grenadzie

Przeprowadzono ponad 100 krajowych i międzynarodowych badań klinicznych – Dr Arroyo specjalizuje się w plazmaferezie w Quironsalud Madrid.

• Kierownik Neurologii w Szpitalu Uniwersyteckim Quironsalud od 2006 r.
• Opublikował 139 międzynarodowych artykułów w czołowych czasopismach, takich jak New England Journal of Medicine
• Profesor Medycyny na Uniwersytecie Europejskim w Madrycie
• Główny badacz w zakresie badań nad stwardnieniem rozsianym

Dr Buse Cagla Ary specjalizuje się w neurologii, ze szczególnym uwzględnieniem plazmaferezy w szpitalu Medipol Acibadem District.

• Certyfikowany neurolog z ponad 8-letnim stażem specjalistycznym
• Ekspert w dziedzinie zaburzeń ruchowych i leczenia neurologicznego
• Członek wielu międzynarodowych towarzystw neurologicznych
• Adiunkt na Wydziale Medycznym Uniwersytetu Bahçeşehir
• Specjalista w zakresie zaawansowanych technik diagnostyki neurologicznej

Dr. Zhang Yan Lin is a nationally recognized nephrologist with over 30 years in clinical care, teaching, and research. Dr. Zhang previously worked at the First Affiliated Hospital of Xiamen University.

Dr. Zhang took part in two NSFC projects, served as principal investigator for one Fujian Provincial NSFC project, and led two Xiamen Municipal key projects. Dr. Zhang is chief editor of one monograph and co-editor of three. Dr. Zhang has published more than 30 papers, including six in SCI journals.

Appointments: Deputy Chair of the Immunoadsorption and Cell Therapy Group of the Internal Medicine Branch of the Chinese Medical Association. Deputy Chair of the Nephrology Branch of the Asia-Pacific Academy of Medical and Biological Immunology. Standing Committee Member of the Nephrology and Dialysis Professional Committee of the China Non-Public Medical Institutions Association. Standing Committee Member of the East China Regional Nephrology Cooperation Committee.

Dr. Pazit Beckerman is a nephrologist with over 24 years of clinical practice in Israel. She specializes in chronic kidney disease (CKD), acute kidney injury (AKI), hemodialysis and peritoneal dialysis, hypertension-related kidney disease, glomerular diseases and proteinuria, electrolyte disorders, and kidney involvement in systemic diseases.

She served as Acting Director in 2020, Deputy Director from 2018 to 2020, and Senior Physician in the Department of Nephrology at Sheba Medical Center. She also heads the Israeli Dialysis Registry.

Education and training: MD, Hebrew University–Hadassah. Nephrology residency, Hadassah. Fellowship in nephrology, Sheba Medical Center. Biomedical Computational Studies, Bar-Ilan University. Postdoctoral fellowship, University of Pennsylvania.

Her research focuses on AKI, immune-related kidney complications, and chronic kidney disease. She has authored many publications. She is a member of the American Society of Nephrology and a board member of the Israeli Society of Nephrology and Hypertension.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Professor Pnina Langevich is a rheumatologist and immunologist with over 40 years of experience. She leads the National Center for Rheumatology and Autoimmune Diseases at Sheba Medical Center. Forbes Israel has repeatedly named her among the country’s top doctors.

She is an expert in rheumatoid arthritis, osteoarthritis, joint diseases, systemic lupus erythematosus, scleroderma, and complex autoimmune disorders. She treats severe, treatment‑resistant cases using advanced diagnostics and personalized therapy.

She trained in rheumatology and internal medicine at Sheba. She combines patient care with research on new therapies. She served for 12 years as Vice President of the World Association of Rheumatologists. She is Editor‑in‑Chief of Lupus and a member of the Israeli Medical Association and the International Association of Rheumatologists.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr Zengin specjalizuje się w neurologii, koncentrując się na złożonych schorzeniach, takich jak stwardnienie rozsiane i miastenia gravis, leczonych w Medicalpoint International Hospital.

• Ukończył wiele prestiżowych uniwersytetów, w tym Dokuz Eylül i Başkent
• Członek Amerykańskiej i Europejskiej Akademii Neurologii
• Ekspert w zaawansowanych metodach leczenia, takich jak pompa apomorfinowa i toksyna botulinowa
• Doświadczony w pracy w szpitalach państwowych na terenie całej Turcji

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Prof. Talip Asil specjalizuje się w plazmaferezie w schorzeniach neurologicznych, szkolony w czołowych instytucjach, w tym University of Calgary i King Hamad University Hospital.

• Ponad 20 lat doświadczenia w neurologii
• Ukończył staż w zakresie leczenia udarów w University of Calgary
• Ekspert w technikach neurologii interwencyjnej
• Były profesor na Wydziale Medycyny Bezmialem
• Praktykuje w Biruni University Hospital